Cyclin-D1-gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product. p53 and p21(WAF1) immunohistochemical expression

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 171-174

  Barbareschi, Mattia ^a   Pelosio, Paola ^b   Caffo, Orazio ^a   Buttitta, Fiamma ^c   Pellegrini, Silvia ^c   Barbazza, Renzo ^b   Dalla Palma, Paolo ^a   Bevilacqua, Generoso ^c   Marchetti, Antonio ^c  

^a SANTA CHIARA HOSPITAL   (Italy)

^b Hospital of Feltre   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST CARCINOMA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030922574     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<171::AID-IJC5>3.0.CO;2-W     Document Type: Article

References (20)

1. ALTUCCI, L., ADDEO, R., CICATIELLO, L., DAUVOIS, S., PARKER, M.G., TRUSS, M., BEATO, SICA, M., V., BRESCIANI, F. and WEISZ, A., 17 beta-estradiol induces cyclin-D-1 gene transcription, p36(D1)-p34(cdk4) complex activation and p105(Rb) phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer. Oncogene, 12, 2315-2324 (1996).
2. WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen-receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Brit. J. Cancer, 74, 208-215 (1996).
3. BARBARESCHI, M., GIRLANDO, S., MAURI, F.A., ARRIGONI, G.L., DALLA PALMA, P. and DOGLIONI, C., Tumor-suppressor-gene products, proliferation and differentiation markers in lung neuro-endocrine neoplasms. J. Pathol., 166, 343-350 (1992).
4. BARTKOVA, J., LUKAS, J., STRAUSS, M. and BARTEK, J., Cyclin-D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10, 775-778 (1995).
5. BUCKLEY, M.F., SWEENEY, K.J., HAMILTON, J.A., SINI, R.L., MANNING, D.L., NICHOLSON, R.I., DEFAZIO, A., WATTS, C.K., MUSGROVE, E.A. and SUTHERLAND, R.L., Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127-2133 (1993).
6. CHEN, X., BARGONETTI, J. and PRIVES, C., p53, through p21 (WAF1/CIP1), induces cyclin-D1 synthesis. Cancer Res., 55, 4257-4263 (1995).
7. DICKSON, C., FANTL, V., GILLETT, C.E., BROOKES, S., BARTEK, J., SMITH, R., FISHER, C., BARNES, D. and PETERS, G., Amplification of chromosome band 11q13 and a role for cyclin-D1 in human breast cancer. Cancer Lett., 90, 43-50 (1995).
8. GILLETT, C.E., FANTL, V. SMITH, R., FISHER, C., BARTEK, J., DICKSON, C., BARNES, D. and PETERS, G., Amplification and over-expression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817 (1994).
9. GILLETT, C.E., SMITH, P., GREGORY, W.M., RICHARDS, M.A., MILLIS, R.R., PETERS, G. and BARNES, D.M., Cyclin D1 and prognosis in breast cancer. Int. J. Cancer (Pred. Oncol.) 69, 92-99 (1996).
10. GJETTING, T., LUKAS, J., BARTEK, J. and STRAUSS, M., Regulated expression of the retinoblastoma susceptibility gene in mammary-carcinoma cells restores cyclin-D1 expression and G(1)-phase control. Biol. Chem. Hoppe-Seyler. 376, 441-446 (1995).
11. MCINTOSH, G.G., ANDERSON, J.J., MILTON, I., STEWARD, M., PARR, A.H., THOMAS, M.D., HENRY, J.A., ANGUS, B., LENNARD, T.W.J. and HORNE, C.H.W., Determination of the prognostic value of cyclin-D1 overexpression in breast cancer. Oncogene. 11, 885-891 (1995).
12. MICHALIDES, R., HAGEMAN, P., VANTINTEREN, H., HOUBEN, L., WIENTJENS, E., KLOMPMAKER, R. and PETERSE, J., A clinicopathological study on over-expression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Brit. J. Cancer, 73, 728-734 (1996).
13. MUSGROVE, E.A., HAMILTON, J.A., LEE, C.S., SWEENEY, K.J., WATTS, C.K. and SUTHERLAND, R.L., Growth factor, steroid and steroid-antagonist regulation of cyclin gene expression associated with changes in T-47D human breast-cancer cell-cycle progression. Mol. cell. Biol., 13, 3577-3587 (1993).
14. PETERS, G., FANTL, V., SMITH, R., BROOKES, S. and DICKSON, C., Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res. Treat., 33, 125-135 (1995).
15. SICINSKI, P., DONAHER, L.J., PARKER, S.B., LI, T., FAZELI, A., GARDNER, H., HASLAM, S.Z., BRONSON, R.T., ELLEDGE, S.J. and WEINBERG, R.A., Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82, 621-630 (1995).
16. 1 phase appears to be required for the development of neoplasia. Nature Med., 1, 1245-1246 (1995).
17. WATTS, C.K.W., SWEENEY, K.J.E., WARLTERS, A., MUSGROVE, E.A. and SUTHERLAND, R.L., Anti-estrogen regulation of cell-cycle progression and cyclin-D1-gene expression in MCF-7 human breast-cancer cells. Breast Cancer Res. Treat., 31, 95-105 (1994).
18. WEINSTAT-SASLOW, D., MERINO, M.J., MANROW, R.E., LAWRENCE, J.A., BLUTH, R.F., WITTENBEL, K.D., SIMPSON, J.F., PAGE, D.L. and STEEG, P.S., Over-expression of cyclin-D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1, 1257-1260 (1996).
19. WORSLEY, S.D., JENNINGS, B.A., KHALIL, K.H., MOLE, M. and GIRLING, A.C., Cyclin-D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen-receptor expression. J. clin. Pathol.-clin. mol. Pathol. 49, M46-M50 (1996).
20. ZUCKERBERG, L.R., YANG, W.I., GADD, M., THOR, A.D., KOERNER, F.C., SCHMIDT, E.V. and ARNOLD, A., Cyclin-D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Modern Pathol. 8, 560-567 (1995).